Nexlizet recalls
Nexlizet products have been recalled 2 times, most recently on 24 Apr 2024. The recalling company is usually Esperion. The most common reason is potency & assay.
Total recalls2since 2023
Last 12 months0reported
Class I00% of total
Ongoing0latest 24 Apr 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 2 100%
Why nexlizet is recalled
Companies
Product types
By year
All nexlizet recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Nexlizet (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg recalledNexlizet | Esperion | Potency & Assay | Nationwide |
| Drug | CLASS III | Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg recalled by EsperionNexlizet | Esperion | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.